See more : New Age Metals Inc. (NAM.V) Income Statement Analysis – Financial Results
Complete financial analysis of Mesa Laboratories, Inc. (MLAB) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Mesa Laboratories, Inc., a leading company in the Hardware, Equipment & Parts industry within the Technology sector.
- CJ Logistics Corporation (000120.KS) Income Statement Analysis – Financial Results
- Baida Group Co.,Ltd (600865.SS) Income Statement Analysis – Financial Results
- Network 1 Financial Group, Inc. (NTFL) Income Statement Analysis – Financial Results
- Spirent Communications plc (SPMYY) Income Statement Analysis – Financial Results
- West Vault Mining Inc. (WVMDF) Income Statement Analysis – Financial Results
Mesa Laboratories, Inc. (MLAB)
About Mesa Laboratories, Inc.
Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 216.19M | 219.08M | 184.34M | 133.94M | 117.69M | 103.14M | 96.18M | 93.67M | 84.66M | 71.33M | 52.72M | 46.44M | 39.62M | 32.83M | 21.93M | 21.54M | 19.56M | 17.24M | 11.58M | 10.04M | 9.13M | 9.08M | 9.04M | 9.10M | 8.66M | 8.10M | 7.90M | 7.80M | 8.10M | 6.60M | 6.20M | 4.40M | 3.80M | 3.50M | 2.80M | 1.10M | 1.00M |
| Cost of Revenue | 82.94M | 85.39M | 75.25M | 46.92M | 52.75M | 42.22M | 41.56M | 40.43M | 33.25M | 27.94M | 21.04M | 17.57M | 16.11M | 13.26M | 8.74M | 7.72M | 6.70M | 6.35M | 4.15M | 3.72M | 3.43M | 3.40M | 3.65M | 3.07M | 2.80M | 2.40M | 2.50M | 2.70M | 2.80M | 2.20M | 2.10M | 1.40M | 1.20M | 1.20M | 1.20M | 400.00K | 400.00K |
| Gross Profit | 133.25M | 133.69M | 109.09M | 87.01M | 64.93M | 60.92M | 54.62M | 53.24M | 51.41M | 43.39M | 31.69M | 28.86M | 23.51M | 19.57M | 13.19M | 13.82M | 12.86M | 10.90M | 7.44M | 6.32M | 5.70M | 5.68M | 5.39M | 6.03M | 5.85M | 5.70M | 5.40M | 5.10M | 5.30M | 4.40M | 4.10M | 3.00M | 2.60M | 2.30M | 1.60M | 700.00K | 600.00K |
| Gross Profit Ratio | 61.64% | 61.02% | 59.18% | 64.97% | 55.17% | 59.06% | 56.79% | 56.84% | 60.73% | 60.83% | 60.10% | 62.16% | 59.35% | 59.61% | 60.17% | 64.16% | 65.74% | 63.19% | 64.21% | 62.94% | 62.44% | 62.59% | 59.61% | 66.30% | 67.62% | 70.37% | 68.35% | 65.38% | 65.43% | 66.67% | 66.13% | 68.18% | 68.42% | 65.71% | 57.14% | 63.64% | 60.00% |
| Research & Development | 19.30M | 20.49M | 15.77M | 10.39M | 6.36M | 3.51M | 3.54M | 4.16M | 3.97M | 3.29M | 2.32M | 2.01M | 1.36M | 1.44M | 669.00K | 636.00K | 532.00K | 392.00K | 358.00K | 358.00K | 332.00K | 259.97K | 289.94K | 308.17K | 281.65K | 200.00K | 300.00K | 300.00K | 300.00K | 400.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 72.87M | 72.44M | 60.31M | 45.70M | 37.83M | 31.30M | 26.26M | 22.81M | 23.62M | 17.06M | 11.46M | 9.12M | 5.42M | 4.58M | 2.54M | 2.52M | 5.27M | 4.84M | 2.97M | 2.49M | 2.12M | 2.24M | 2.16M | 2.40M | 2.39M | 2.20M | 2.10M | 2.10M | 2.30M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 38.63M | 37.44M | 28.31M | 18.48M | 12.91M | 8.26M | 8.82M | 9.96M | 7.50M | 7.18M | 6.12M | 4.63M | 3.91M | 3.69M | 2.62M | 3.05M | 2.85B | 2.77B | 1.88B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 111.49M | 109.88M | 88.62M | 64.18M | 50.74M | 39.56M | 35.08M | 32.77M | 31.12M | 24.23M | 17.58M | 13.75M | 9.33M | 8.26M | 5.16M | 5.57M | 5.27M | 4.84M | 2.97M | 2.49M | 2.12M | 2.24M | 2.16M | 2.40M | 2.39M | 2.20M | 2.10M | 2.10M | 2.30M | 1.80M | 2.30M | 1.60M | 1.30M | 1.20M | 1.00M | 600.00K | 600.00K |
| Other Expenses | 274.53M | -3.71M | -1.13M | 91.00K | 50.00K | -1.16M | -1.88M | -2.02M | -768.00K | -517.00K | 1.32M | -126.00K | 350.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 332.59K | 200.00K | 200.00K | 200.00K | 300.00K | 300.00K | 200.00K | 100.00K | 100.00K | 200.00K | 100.00K | 0.00 | 0.00 |
| Operating Expenses | 406.55M | 130.37M | 104.39M | 74.66M | 57.14M | 43.06M | 38.62M | 36.93M | 35.09M | 27.53M | 19.90M | 15.76M | 10.68M | 9.70M | 5.83M | 6.21M | 5.80M | 5.24M | 3.33M | 2.85M | 2.45M | 2.50M | 2.45M | 2.71M | 3.01M | 2.60M | 2.60M | 2.60M | 2.90M | 2.50M | 2.50M | 1.70M | 1.40M | 1.40M | 1.10M | 600.00K | 600.00K |
| Cost & Expenses | 488.26M | 215.76M | 179.63M | 121.58M | 109.90M | 85.28M | 80.18M | 77.35M | 68.34M | 55.47M | 40.94M | 33.33M | 26.79M | 22.96M | 14.56M | 13.93M | 12.50M | 11.58M | 7.47M | 6.57M | 5.88M | 5.90M | 6.10M | 5.77M | 5.81M | 5.00M | 5.10M | 5.30M | 5.70M | 4.70M | 4.60M | 3.10M | 2.60M | 2.60M | 2.30M | 1.00M | 1.00M |
| Interest Income | 0.00 | 4.77M | 3.89M | 107.00K | 960.00K | 1.72M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 86.00K | 195.00M | 130.00M | 193.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 5.70M | 3.71M | 3.89M | 8.02M | 5.50M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 31.57M | 33.13M | 25.07M | 17.47M | 12.87M | 9.47M | 9.47M | 8.74M | 7.17M | 5.66M | 3.84M | 3.43M | 2.22M | 1.84M | 786.00K | 788.00K | 742.00K | 669.00K | 93.00K | 90.00K | 97.00K | 115.35K | 115.09K | 521.69K | 332.59K | 200.00K | 200.00K | 200.00K | 300.00K | 300.00K | 200.00K | 100.00K | 100.00K | 200.00K | 100.00K | 0.00 | 0.00 |
| EBITDA | -238.38M | 36.45M | 29.77M | 12.36M | 8.09M | 18.09M | 9.77M | 25.05M | 23.50M | 21.52M | 15.63M | 16.54M | 14.55M | 11.71M | 8.15M | 8.40M | 7.80M | 6.33M | 4.20M | 3.57M | 3.35M | 3.30M | 3.06M | 3.85M | 3.18M | 3.30M | 3.20M | 2.70M | 2.70M | 2.20M | 1.80M | 1.40M | 1.30M | 1.10M | 600.00K | 100.00K | 0.00 |
| EBITDA Ratio | -110.26% | 1.52% | 2.55% | 9.23% | 6.87% | 34.28% | 31.01% | 17.42% | 19.28% | 22.24% | 22.35% | 28.22% | 39.22% | 36.01% | 33.76% | 38.99% | 39.90% | 36.70% | 36.29% | 35.50% | 36.66% | 36.36% | 33.80% | 43.13% | 36.72% | 37.04% | 35.44% | 33.33% | 32.10% | 33.33% | 29.03% | 29.55% | 31.58% | 31.43% | 21.43% | 9.09% | 0.00% |
| Operating Income | -272.08M | -30.50M | -20.37M | -5.30M | -4.90M | 9.78M | 2.18M | 16.31M | 16.32M | 15.86M | 11.79M | 13.10M | 12.48M | 9.86M | 7.37M | 7.61M | 7.06M | 5.66M | 4.11M | 3.48M | 3.25M | 3.19M | 2.94M | 2.81M | 2.85M | 3.10M | 2.80M | 2.50M | 2.40M | 1.90M | 1.60M | 1.30M | 1.20M | 900.00K | 500.00K | 100.00K | 0.00 |
| Operating Income Ratio | -125.85% | -13.92% | -11.05% | -3.96% | -4.16% | 9.48% | 2.27% | 17.42% | 19.28% | 22.24% | 22.35% | 28.22% | 31.49% | 30.05% | 33.60% | 35.33% | 36.10% | 32.82% | 35.48% | 34.61% | 35.60% | 35.09% | 32.53% | 30.84% | 32.87% | 38.27% | 35.44% | 32.05% | 29.63% | 28.79% | 25.81% | 29.55% | 31.58% | 25.71% | 17.86% | 9.09% | 0.00% |
| Total Other Income/Expenses | -3.57M | -3.71M | -1.13M | -10.06M | -4.06M | -1.16M | -1.88M | -2.02M | -768.00K | -517.00K | 1.32M | -126.00K | -146.00K | -113.00K | 36.00K | 86.00K | 195.00K | 130.00K | 193.00K | 98.00K | 50.00K | 55.16K | 78.51K | 70.96K | 243.83K | 100.00K | 400.00K | 100.00K | 0.00 | -100.00K | -100.00K | 0.00 | 100.00K | 100.00K | 0.00 | 100.00K | 0.00 |
| Income Before Tax | -275.65M | -389.00K | 3.57M | 2.30M | 3.43M | 8.62M | 301.00K | 14.30M | 15.56M | 15.35M | 13.10M | 12.98M | 12.33M | 9.75M | 7.40M | 7.69M | 7.26M | 5.79M | 4.30M | 3.57M | 3.30M | 3.24M | 3.02M | 2.88M | 3.09M | 3.20M | 3.20M | 2.60M | 2.40M | 1.80M | 1.50M | 1.30M | 1.30M | 1.00M | 0.00 | 200.00K | 0.00 |
| Income Before Tax Ratio | -127.50% | -0.18% | 1.94% | 1.72% | 2.92% | 8.36% | 0.31% | 15.26% | 18.37% | 21.52% | 24.85% | 27.95% | 31.13% | 29.71% | 33.76% | 35.73% | 37.10% | 33.57% | 37.15% | 35.58% | 36.15% | 35.69% | 33.40% | 31.62% | 35.69% | 39.51% | 40.51% | 33.33% | 29.63% | 27.27% | 24.19% | 29.55% | 34.21% | 28.57% | 0.00% | 18.18% | 0.00% |
| Income Tax Expense | -21.40M | -1.32M | 1.70M | -971.00K | 2.08M | 1.14M | 3.26M | 3.11M | 4.39M | 5.76M | 4.10M | 4.53M | 4.41M | 3.57M | 2.64M | 2.90M | 2.65M | 1.83M | 1.50M | 1.26M | 1.17M | 1.11M | 989.66K | 1.05M | 982.46K | 1.10M | 1.10M | 900.00K | 800.00K | 600.00K | 500.00K | 400.00K | 400.00K | 100.00K | 100.00K | 100.00K | 0.00 |
| Net Income | -254.25M | 930.00K | 1.87M | 3.27M | 1.35M | 7.48M | -2.96M | 11.18M | 11.17M | 9.58M | 9.00M | 8.45M | 7.92M | 6.18M | 4.77M | 4.79M | 4.61M | 3.96M | 2.81M | 2.31M | 2.13M | 2.13M | 2.03M | 1.83M | 2.11M | 2.10M | 2.10M | 1.70M | 1.60M | 1.20M | 1.00M | 900.00K | 900.00K | 900.00K | 400.00K | 100.00K | 0.00 |
| Net Income Ratio | -117.60% | 0.42% | 1.01% | 2.44% | 1.15% | 7.26% | -3.08% | 11.94% | 13.19% | 13.43% | 17.07% | 18.20% | 19.99% | 18.84% | 21.75% | 22.24% | 23.57% | 22.96% | 24.22% | 23.03% | 23.34% | 23.42% | 22.46% | 20.13% | 24.34% | 25.93% | 26.58% | 21.79% | 19.75% | 18.18% | 16.13% | 20.45% | 23.68% | 25.71% | 14.29% | 9.09% | 0.00% |
| EPS | -47.20 | 0.17 | 0.36 | 0.66 | 0.32 | 1.95 | -0.79 | 3.04 | 3.10 | 2.72 | 2.61 | 2.52 | 2.41 | 1.91 | 1.49 | 1.51 | 1.46 | 1.25 | 0.94 | 0.76 | 0.70 | 0.66 | 0.60 | 0.59 | 0.55 | 0.51 | 0.48 | 0.39 | 0.29 | 0.29 | 0.23 | 0.21 | 0.21 | 0.20 | 0.10 | 0.04 | 0.01 |
| EPS Diluted | -47.20 | 0.17 | 0.35 | 0.64 | 0.31 | 1.86 | -0.79 | 2.91 | 2.97 | 2.63 | 2.49 | 2.35 | 2.29 | 1.86 | 1.45 | 1.48 | 1.41 | 1.22 | 0.92 | 0.74 | 0.68 | 0.64 | 0.59 | 0.59 | 0.55 | 0.50 | 0.47 | 0.39 | 0.29 | 0.29 | 0.23 | 0.21 | 0.21 | 0.20 | 0.10 | 0.04 | 0.01 |
| Weighted Avg Shares Out | 5.39M | 5.32M | 5.21M | 4.98M | 4.20M | 3.84M | 3.75M | 3.68M | 3.61M | 3.52M | 3.45M | 3.36M | 3.29M | 3.23M | 3.19M | 3.18M | 3.17M | 3.16M | 2.99M | 3.06M | 3.05M | 3.23M | 3.41M | 3.69M | 3.82M | 4.14M | 4.30M | 4.47M | 4.33M | 4.14M | 4.35M | 4.29M | 4.29M | 4.50M | 4.00M | 2.50M | 3.48M |
| Weighted Avg Shares Out (Dil) | 5.39M | 5.36M | 5.34M | 5.12M | 4.37M | 4.03M | 3.77M | 3.84M | 3.76M | 3.65M | 3.61M | 3.59M | 3.46M | 3.33M | 3.29M | 3.24M | 3.28M | 3.23M | 3.05M | 3.14M | 3.14M | 3.30M | 3.45M | 3.72M | 3.84M | 4.17M | 4.40M | 4.47M | 4.33M | 4.14M | 4.35M | 4.29M | 4.29M | 4.50M | 4.00M | 2.50M | 3.48M |
Earnings Estimates Moving Higher for Mesa Labs (MLAB): Time to Buy?
Mesa Labs (MLAB) Q2 Earnings and Revenues Top Estimates
Mesa Labs (MLAB) Q1 Earnings and Revenues Miss Estimates
Mesa Labs (MLAB) Surpasses Q4 Earnings and Revenue Estimates
RVT: 8% Dividend Yield With Upside To Valuation
Mesa Labs (MLAB) Q3 Earnings Miss Estimates
My 3 Favorite Under-the-Radar Healthcare Stocks for 2022
What History Shows Us About 2022 Market Returns
Bull of the Day: Mesa Laboratories (MLAB)
Analysts Estimate Mesa Labs (MLAB) to Report a Decline in Earnings: What to Look Out for
Source: https://incomestatements.info
Category: Stock Reports